Peanut-Allergic Toddlers Also Benefit From Oral Immunotherapy With Palforzia Peanut-Allergic Toddlers Also Benefit From Oral Immunotherapy With Palforzia

New research findings show that an FDA-approved oral immunotherapy for older children and adolescents safely increased peanut protein tolerance in peanut-allergic children aged 1-3 years.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news